Insider Trends: Insider Prolongs 90-Day Selling Trend at Amgen
10:52 PM EST, 02/05/2021 (MT Newswires) -- Jonathan P Graham, EVP, Gen. Counsel & Secy., sold 11,110 shares in Amgen (AMGN) for $2,627,625 on Feb 04, 2021. Graham, following the transactions delineated in the Form 4 SEC filing, owns 39,945 shares of company stock, with a market value, based on the prior-day closing price, of $9.48 million.
During the most recent 90-day period, previous to the date of this filing, there have been 3 insider transactions reported to the SEC for Amgen. These transactions came from the activities of 2 separate insiders that resulted in a net disposition of 250 company shares. Relative to the preceding 90-day window of time, there were 6 transactions from 5 insiders and resulted in the net disposition of 6,801 shares.
This level of insider transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 59.1 transactions per company, and disposition of 8,109 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/318154/000112760221004257/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.